| Ferric carboxymaltose in patients with heart failure and iron deficiency SD Anker, J Comin Colet, G Filippatos, R Willenheimer, K Dickstein, ... New England Journal of Medicine 361 (25), 2436-2448, 2009 | 2548 | 2009 |
| Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency P Ponikowski, DJ Van Veldhuisen, J Comin-Colet, G Ertl, M Komajda, ... European heart journal 36 (11), 657-668, 2015 | 1425 | 2015 |
| Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron‐deficient heart failure patients: an individual patient data meta‐analysis SD Anker, BA Kirwan, DJ van Veldhuisen, G Filippatos, J Comin‐Colet, ... European journal of heart failure 20 (1), 125-133, 2018 | 494 | 2018 |
| Intravenous ferric carboxymaltose in iron‐deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR‐HF trial G Filippatos, D Farmakis, JC Colet, K Dickstein, TF Lüscher, ... European journal of heart failure 15 (11), 1267-1276, 2013 | 209 | 2013 |
| The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study J Comin-Colet, M Lainscak, K Dickstein, GS Filippatos, P Johnson, ... European heart journal 34 (1), 30-38, 2013 | 200 | 2013 |
| Rationale and design of Ferinject® Assessment in patients with IRon deficiency and chronic Heart Failure (FAIR‐HF) study: a randomized, placebo‐controlled study of intravenous … SD Anker, JC Colet, G Filippatos, R Willenheimer, K Dickstein, H Drexler, ... European journal of heart failure 11 (11), 1084-1091, 2009 | 144 | 2009 |
| The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR‐HF study P Ponikowski, G Filippatos, JC Colet, R Willenheimer, K Dickstein, ... European Journal of Heart Failure 17 (3), 329-339, 2015 | 133 | 2015 |
| Minimal clinically important difference in quality of life scores for patients with heart failure and reduced ejection fraction J Butler, MS Khan, C Mori, GS Filippatos, P Ponikowski, J Comin‐Colet, ... European Journal of Heart Failure 22 (6), 999-1005, 2020 | 105 | 2020 |
| CONFIRM-HF Investigators. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency P Ponikowski, DJ Van Veldhuisen, J Comin-Colet, G Ertl, M Komajda, ... Eur Heart J 36 (11), 657-668, 2015 | 78 | 2015 |
| Health economic assessment of ferric carboxymaltose in patients with iron deficiency and chronic heart failure based on the FAIR‐HF trial: an analysis for the UK FS Gutzwiller, M Schwenkglenks, PR Blank, PG Braunhofer, C Mori, ... European journal of heart failure 14 (7), 782-790, 2012 | 68 | 2012 |
| Identification of three additional femAB-like open reading frames in Staphylococcus aureus M Tschierske, C Mori, S Rohrer, K Ehlert, KJ Shaw, B Berger-Bächi FEMS microbiology letters 171 (2), 97-102, 1999 | 65 | 1999 |
| Rationale and design of the CONFIRM‐HF study: a double‐blind, randomized, placebo‐controlled study to assess the effects of intravenous ferric carboxymaltose on functional … P Ponikowski, DJ Van Veldhuisen, J Comin‐Colet, G Ertl, M Komajda, ... ESC heart failure 1 (1), 52-58, 2014 | 62 | 2014 |
| Site-specific serine incorporation by Lif and Epr into positions 3 and 5 of the staphylococcal peptidoglycan interpeptide bridge K Ehlert, M Tschierske, C Mori, W Schröder, B Berger-Bächi Journal of bacteriology 182 (9), 2635-2638, 2000 | 58 | 2000 |
| Determinants of quality of life of patients with heart failure and iron deficiency treated with ferric carboxymaltose: FAIR-HF sub-analysis FS Gutzwiller, AM Pfeil, J Comin-Colet, P Ponikowski, G Filippatos, C Mori, ... International journal of cardiology 168 (4), 3878-3883, 2013 | 53 | 2013 |
| FAIR-HF committees and investigators. Rationale and design of Ferinject assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized … SD Anker, JC Colet, G Filippatos, R Willenheimer, K Dickstein, H Drexler, ... Eur J Heart Fail 11 (11), 1084-91, 2009 | 52 | 2009 |
| The effect of intravenous ferric carboxymaltose on red cell distribution width: a subanalysis of the FAIR‐HF study EM Van Craenenbroeck, VM Conraads, N Greenlaw, G Gaudesius, ... European journal of heart failure 15 (7), 756-762, 2013 | 44 | 2013 |
| Differences between intravenous iron products: focus on treatment of iron deficiency in chronic heart failure patients A Martin‐Malo, G Borchard, B Flühmann, C Mori, D Silverberg, ... ESC heart failure 6 (2), 241-253, 2019 | 42 | 2019 |
| Intravenous iron preparations transiently generate non-transferrin-bound iron from two proposed pathways MW Garbowski, S Bansal, JB Porter, C Mori, S Burckhardt, RC Hider Haematologica 106 (11), 2885, 2021 | 39 | 2021 |
| Effect of ferric carboxymaltose on calculated plasma volume status and clinical congestion: a FAIR‐HF substudy DO Okonko, F Jouhra, H Abu‐Own, G Filippatos, JC Colet, C Suki, C Mori, ... ESC Heart Failure 6 (4), 621-628, 2019 | 23 | 2019 |
| Relation of longitudinal changes in quality of life assessments to changes in functional capacity in patients with heart failure with and without anemia TJ Cooper, SD Anker, J Comin-Colet, G Filippatos, M Lainscak, ... The American journal of cardiology 117 (9), 1482-1487, 2016 | 18 | 2016 |
